The medical device reprocessing market is expected to accelerate

The global medical device reprocessing market was valued at USD 1.4 billion in 2020. It is expected to grow at a compound annual growth rate (CAGR) of 16% through 2031, exceeding USD 3 billion. The demand for reprocessing support and services is expected to grow at a compound annual growth rate (CAGR) of 15% during the evaluation period from 2021 to 2031.

The main factors driving the growth of this market are the lower costs of reconditioned devices compared to new ones and the increasing pressure to reduce the amount of medical waste generated.

Download a sample copy of this report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=6721

Analysis by country

In the U.S., the medical device reprocessing market was valued at $323 million in 2020. The U.S. Food and Drug Administration (FDA) mandates that third-party reprocessors meet the same standards required for originally manufactured single-use devices.

Reprocessing is common practice in the U.S., and hospitals are increasingly choosing to reprocess single-use devices. About 45% of U.S. hospitals have contracts with third-party reprocessors, making chronic disease management more affordable for low-income patients.

Analysis by category

Revenues from remanufactured cardiovascular medical devices account for over 52% of the market share. The introduction of inexpensive remanufactured cardiovascular devices has led to widespread use worldwide.

Moreover, the growing geriatric population, which is more prone to cardiovascular disorders, is driving the demand for the products. Low-income groups tend to favor recycled medical devices due to their affordability, which further boosts the market growth.

The COVID-19 pandemic has raised safety concerns among clinicians and patients regarding the reuse of medical devices, which has negatively impacted the demand for reused products.

In response to these safety concerns, regulatory authorities have introduced mandatory sterilization and microbiological testing of reprocessed medical devices.

Read more: https://www.factmr.com/report/medical-device-reprocessing-market

Competitive environment

Large companies implement strategies such as investing in research and development, introducing new market initiatives, expanding production facilities, introducing new products, obtaining product approvals and obtaining patents.

In May 2019, Medtronic received US FDA approval for the Select Site C304-HIS deflectable Catheter system for use in His bundle stimulation (HBP) procedures. This strategic move helped the company generate additional revenue and strengthen its position in the industry.
In April 2019, 3M expanded its advanced medical adhesive offering with the introduction of 3M Extended Wear Medical Transfer Adhesive (4075), broadening its product portfolio.
In September 2018, Vanguard announced the acquisition of Pioneer Medical Devices AG to enhance its medical device reprocessing services, strengthening the company’s product offering in the global marketplace.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:

https://www.factmr.com/connectus/sample?flag=S&rep_id=6721

Key Segments Covered in Medical Device Reprocessing Industry Research

By product and service
Reprocessing support and services
Recycling of medical devices
By device
Catheters
Laparoscopy tools
Biopsy Tools
Endoscopic instruments
Cables, Columns, Curves and Cutters
By application
Cardiology
Gastroenterology, Urology and Gynecology
Arthroscopy and orthopedic surgery
General Surgery and Anesthesiology
By region
North America
Europe
Asia and Pacific
Central and South America
Middle East and Africa

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Apartment 400
Rockville, MD 20852
United States
Phone: +1 (628) 251-1583, +353-1-4434-232
Email address: [email protected]

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑

We are a trusted research partner to 80% of the Fortune 1000 companies worldwide. We continue to advance the market research landscape, publishing over 1000 reports annually. Our dedicated team of over 400 analysts and consultants is committed to achieving the highest level of customer satisfaction.

This version was published on openPR.